Sebacia

About:

Sebacia is a commercial-stage dermatology company that develops an alternative to the topical and systemic drugs for the treatment of acne.

Website: http://www.sebacia.com

Twitter/X: sebacianews

Top Investors: Hercules Capital, Versant Ventures, Domain Associates, Salem Partners, Partners Innovation Fund

Description:

Sebacia, Inc. is a private medical device company dedicated to creating breakthrough topical therapies for the treatment of dermatological conditions affecting millions of people. Sebacia's goal is to provide a better alternative to the daily use of topical and systemic drugs currently available for the treatment of acne. Sebacia's patented microparticles technology was invented at Rice University, and the proprietary dermatology applications were further developed with researchers from the Wellman Center of Photomedicine at Massachusetts General Hospital. Sebacia is located in Duluth, Georgia.

Total Funding Amount:

$102M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Duluth, Georgia, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)sebacia.com

Founders:

Anthony Lando

Number of Employees:

11-50

Last Funding Date:

2019-08-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai